Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study Meeting Abstract
| Authors: | von Mehren, M.; Heinrich, C.; George, S.; Zalcberg, J. R.; Bauer, S.; Gelderblom, H.; Schöffski, P.; Serrano, C.; Jones, R. L.; Attia, S.; D'Amato, G.; Chi, P.; Reichardt, P.; Meade, J. N.; Reichert, V. L.; Shi, K.; Ruiz-Soto, R.; Blay, J. Y. |
| Abstract Title: | Ripretinib as ≥4th-line treatment in patients with advanced gastrointestinal stromal tumor: Long-term update from the phase III INVICTUS study |
| Meeting Title: | ESMO Congress 2021 |
| Journal Title: | Annals of Oncology |
| Volume: | 32 |
| Issue: | Suppl. 5 |
| Meeting Dates: | 2021 Sep 16-21 |
| Meeting Location: | Virtual |
| ISSN: | 0923-7534 |
| Publisher: | Oxford University Press |
| Date Published: | 2021-09-01 |
| Start Page: | S1120 |
| End Page: | S1121 |
| Language: | English |
| ACCESSION: | WOS:000700527703087 |
| DOI: | 10.1016/j.annonc.2021.08.870 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: 1540P -- Source: Wos |
